BROADWOOD CAPITAL INC Long-Term Concentrated

CIK: 0001278387 · Show all filings

Period: Q4 2018 (← Previous) (Next →)

Filing Date: Feb 14, 2019

Total Value ($000): $712,587 (100.0% shares, 0.0% debt)

Holdings (8)

STAA STAAR SURGICAL CO 48.1%

Value ($000) $342,734 Shares 10,740,630 Est. Cost $8.21 Unrealized +374.6%

MNST MONSTER BEVERAGE CORP NEW 32.3%

Value ($000) $230,316 Shares 4,679,308 Est. Cost $22.71 Unrealized +19.6%

IWM ISHARES TR 7.9%

Value ($000) $56,238 Shares 420,000 Est. Cost $109.78 Unrealized —

AXON AXON ENTERPRISE INC 4.7%

Value ($000) $33,253 Shares 760,062 Est. Cost $27.50 Unrealized +88.7%

— BIOTIME INC 3.8%

Value ($000) $27,364 Shares 29,971,561 Est. Cost $3.37 Unrealized —

— ONCOCYTE CORPORATION 1.5%

Value ($000) $10,440 Shares 7,564,934 Est. Cost $3.90 Unrealized —

— AGEX THERAPEUTICS INC 1.3%

Value ($000) $8,961 Shares 2,997,156 Est. Cost $2.99 Unrealized —

— ASTERIAS BIOTHERAPEUTICS INC 0.5%

Value ($000) $3,281 Shares 5,292,156 Est. Cost $3.30 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
STAA	STAAR SURGICAL CO	10,740,630	$342,734	48.1%	$8.21	+374.6%	COM PAR $0.01	852312305
MNST	MONSTER BEVERAGE CORP NEW	4,679,308	$230,316	32.3%	$22.71	+19.6%	COM	61174X109
IWM	ISHARES TR	420,000	$56,238	7.9%	$109.78	—	RUSSELL 2000 ETF	464287655
AXON	AXON ENTERPRISE INC	760,062	$33,253	4.7%	$27.50	+88.7%	COM	05464C101
—	BIOTIME INC	29,971,561	$27,364	3.8%	$3.37	—	COM	09066L105
—	ONCOCYTE CORPORATION	7,564,934	$10,440	1.5%	$3.90	—	COM	68235C107
—	AGEX THERAPEUTICS INC	2,997,156	$8,961	1.3%	$2.99	—	COM	00848H108
—	ASTERIAS BIOTHERAPEUTICS INC	5,292,156	$3,281	0.5%	$3.30	—	COM SER A	04624N107